Generics BulletinMultiple biosimilars and a generic medicine received positive opinions from the European Medicines Agency’s Committee for Medicinal Products for Human Use at the end of July. While positive opinions d
Generics BulletinBiocon Biologics has launched its Nepexto (etanercept) biosimilar in Australia, referencing Amgen’s brand Enbrel. The biosimilar will be promoted by the Indian firm’s local partner, Generic Health, wh
Generics BulletinBiocon Biologics has celebrated approval of its Kirsty (insulin aspart-xjhz) 100 units/ml biosimilar rival to Novo Nordisk’s Novolog by the US Food and Drug Administration, indicated to improve glycem
Generics BulletinThe UK Medicines and Healthcare products Regulatory Agency has approved Biocon Biologics’ two denosumab biosimilars. Set to be marketed under the name Vevzuo, referencing Amgen’s Xgeva brand, the bios